USPTO serial 78102689
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Clarke Weber
CYNTHIA CLARKE WEBER SUGHRUE MION, PLLC2100 PENNSYLVANIA AVE N WWASHINGTON, DC 20037-3213UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations used in the manufacture of research tools, drug discovery tools, drug candidates and drugs for use in the pharmaceutical, biotechnological and veterinary industry, and for use in research and science; biochemical preparations, namely cells, vectors, plasmids or combinations thereof in assays for laboratory analyses and for in vivo analysis in scientific research for laboratory use; raw material protein, namely, proteins isolated from cells or synthesized proteins and bio-molecular vectors, the aforesaid goods for use in the manufacture of research tools, pharmaceutical and veterinarian drugs, drug discovery tools and pharmaceutical and veterinarian drug candidates; polypeptides, peptides and nucleic acids for laboratory use | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for medical and veterinary use namely, for use in the treatment of cancer, inflammatory diseases, immunology diseases, infectious diseases, diabetes, hypertension and depression, muscoskeletal diseases and cardiological and vascular diseases and disorders, pulmonary and respiratory diseases, endocrine diseases and disorders, gastroenterological diseases, hematological diseases, nephrological and urological diseases, neurological diseases, ophthalmological diseases, otolaryngological diseases, rheumatological diseases and diseases and conditions related to trauma and emergency; biochemical preparations, namely, cells, vectors, plasmids or combinations thereof in assays for use in medical research and for vivo analyses in medical science; proteins; polypeptides, peptides and nucleic acids for medical and veterinarian purposes and bio-molecular vectors for medical or veterinarian purposes used in the manufacture of medical research tools, drug discovery tools, pharmaceutical and veterinarian drug candidates and drugs | SECTION 8 - CANCELLED | — |
| 042 | Scientific, industrial, biotechnological and biomedical research; development and identification of drugs and drug candidates; chemical, biochemical, and biomolecular analysis; in vivo and in vitro pre-clinical test of drug candidates; consultation services in the field of development and identification of drugs and drug candidates; medical research; screening services used in connection with the development and identification of pharmaceutical and veterinarian drugs and drug candidates | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 15, 2010 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 28, 2008 | CFIT | CASE FILE IN TICRS | — |
| Oct 7, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 15, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 28, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Dec 31, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 24, 2002 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Oct 24, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2002 | PAPER RECEIVED | — | |
| May 8, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2002 | DOCK | ASSIGNED TO EXAMINER | — |